The cardiac ryanodine receptor (RyR2) is inhibited by calmodulin (CaM) and S100A1. D/D mice showed a 9% increase in heart weight-to-body weight ratio, modest changes in cardiac morphology, and a twofold increase in atrial natriuretic peptide mRNA levels compared with wild type. After 4-wk pressure overload with transverse aortic constriction, heart weight-to-body weight ratio and atrial natriuretic peptide mRNA levels increased and echocardiography showed changes in heart morphology of Ryr2 D/D mice compared with sham-operated mice. Collectively, the findings indicate that the single RyR2-L3591D mutation, which distinguishes the effects of diastolic and systolic Ca 2ϩ , alters heart size and cardiac function to a lesser extent in Ryr2 D/D mice than the triple mutation in Ryr2 ADA/ADA mice. They further suggest that CaM inhibition of RyR2 at systolic Ca 2ϩ is important for maintaining normal cardiac function.
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). Here we report that in single-channel measurements RyR2-L3591D isolated from Ryr2 D/D hearts lost CaM inhibition at diastolic Ca 2ϩ only, whereas S100A1 regulation was eliminated at both diastolic and systolic Ca 2ϩ . In contrast to the ϳ2-wk life span of Ryr2 ADA/ADA mice, Ryr2 D/D mice lived longer than 1 yr. Six-month-old Ryr2 D/D mice showed a 9% increase in heart weight-to-body weight ratio, modest changes in cardiac morphology, and a twofold increase in atrial natriuretic peptide mRNA levels compared with wild type. After 4-wk pressure overload with transverse aortic constriction, heart weight-to-body weight ratio and atrial natriuretic peptide mRNA levels increased and echocardiography showed changes in heart morphology of Ryr2 D/D mice compared with sham-operated mice. Collectively, the findings indicate that the single RyR2-L3591D mutation, which distinguishes the effects of diastolic and systolic Ca 2ϩ , alters heart size and cardiac function to a lesser extent in Ryr2 D/D mice than the triple mutation in Ryr2 ADA/ADA mice. They further suggest that CaM inhibition of RyR2 at systolic Ca 2ϩ is important for maintaining normal cardiac function.
cardiac ryanodine receptor; calmodulin; S100A1; cardiac hypertrophy CARDIAC MUSCLE RYANODINE RECEPTORS (RyR2s) are large, ligand-gated ion channels composed of four 560-kDa RyR2 subunits, four 12.6-kDa FK506 binding protein subunits, and various associated proteins that include protein kinases, protein phosphatases, S100A1, and calmodulin (CaM) (11, 17, 19, 30) . Binding of CaM to RyR2 inhibits the release of Ca 2ϩ from sarcoplasmic reticulum (SR) at diastolic and systolic Ca 2ϩ (2, 8, 19, 31) . Deletion of RyR2 amino acid residues 3583-3603 and mutations in this region eliminate CaM binding and inhibition of the recombinant RyR2 by CaM in vitro (36) . An in vivo role of RyR2 regulation by CaM was established by preparing mutant mice with three amino acid substitutions in the CaM binding domain of RyR2 (W3587A, L3591D, F3603A; RyR2 ADA ). Ryr2 ADA/ADA mice die within ϳ2 wk after birth because of the rapid development of cardiac hypertrophy and heart failure (35) . Their early death is associated with abnormal SR Ca 2ϩ release and altered gene regulation (33, 35) . S100A1 is a small Ca 2ϩ binding protein expressed at high levels in cardiomyocytes (13) . S100A1 targets multiple sites that include sarcomeric proteins, mitochondrial proteins, and Ca 2ϩ handling proteins Ca v 1.2, RyR2, and sarco(endo)plasmic reticulum Ca 2ϩ -ATPase (SERCA)2a and SERCA2a regulatory protein phospholamban (PLN) (10, 21, 24, 29) . S100A1 also regulates skeletal muscle RyR1 and binds to the conserved CaM binding domain of RyR1 (25, 27) . S100A1 Ϫ/Ϫ mice have normal life span and cardiac function under normal conditions (7) . However, transgenic overexpression of S100A1 increases SR Ca 2ϩ content and Ca 2ϩ release and improves myocardial contractile performance (21) . More recent studies have shown that molecular targeting of S100A1 to myocardially infarcted animals (23) and human failing cardiomyocytes (4) restores cardiac function by improving mitochondrial function, SR Ca 2ϩ handling, and contractile performance. This suggested that S100A1 gene targeting may be a promising strategy to treat heart failure.
To further define the role of RyR2 and Ca 2ϩ in cardiac development and function, a second mouse model was prepared with a single amino acid substitution in the CaM and S100A1 binding domain of RyR2 (L3591D; RyR2 D ). This mutation was selected on the basis of earlier studies showing that the RyR2-L3591D mutant is inhibited by CaM at micromolar Ca 2ϩ but not submicromolar Ca 2ϩ concentrations when expressed in human embryonic kidney 293 (HEK293) cells (36 
MATERIALS AND METHODS
Ethics statement. This study was carried out in strict accordance with the recommendations in the Guide for the Care and Use of Laboratory Animals of the National Institutes of Health. The protocols were approved by the University of North Carolina at Chapel Hill and the Medical University of South Carolina Institutional Animal Care and Use Committees. Animals were anesthetized and killed with 1-4% isoflurane (drop method) or intraperitoneal injection of Avertin (160 mg/kg) followed by physical euthanasia.
Materials. [ 3 H]ryanodine was obtained from PerkinElmer and unlabeled ryanodine from EMD Biosciences. Complete protease inhibitors were from Roche Applied Science and phospholipids from Avanti Polar Lipids. Unlabeled CaM was prepared as described previously (2) . Rabbit polyclonal antibody RyR2-F9221 was prepared by New England Peptide (Gardner, MA). Unless otherwise specified, all other chemicals were obtained from Sigma-Aldrich.
Preparation of mutant mice. Mutant mice carrying the RyR2-L3591D mutation were prepared with established methods (35) . Briefly, linearized targeting vector was transfected into E14 embryonic stem (ES) cells by electroporation. Cells were selected in the presence of G418 and gancyclovir and screened by both PCR and Southern blot analysis. Mutations were confirmed by DNA sequencing. Targeted ES cells were injected into the blastocysts of C57BL/6J mice in the Animal Models Core Facility of the University of North Carolina at Chapel Hill. A male chimera mouse carrying the mutation in the Ryr2 gene was mated with a 129/SvEv female mouse to obtain heterozygous offspring. The neomycin-resistant gene flanked by loxP sequences was removed by Cre recombinase driven by the testisspecific angiotensin-converting enzyme promoter (Fig. 1) . Germ line transmission of the mutation to heterozygous offspring caused removal of a gene cassette flanked by loxP sequences (5 Hearts from 6-to 7-mo-old mice were fixed with 4% (wt/vol) paraformaldehyde in PBS (pH 7.4) and dehydrated with increasing concentrations of ethanol in water. Paraffin-embedded hearts were sectioned into 6-to 9-m thickness and stained with hematoxylin and eosin. Tetramethylrhodamine isothiocyanate (TRITC)-conjugated wheat germ agglutinin was used to visualize the cell membranes in the sections (35) . TRITC fluorescence was captured by confocal microscopy (Leica TCS SP5), and crosssectional areas of individual cells in left and right ventricles and interventricular septum were calculated with ImageJ software. Thirty cells were randomly selected from wild-type and mutant mice.
Echocardiography. Left ventricular cardiac parameters were determined by transthoracic M-mode echocardiography on restrained mice with a Vevo 2100 high-resolution imaging system (VisualSonics) with a 40-MHz probe. Unanesthetized 4-and 6-mo-old mice were restrained on a warmed mouse board (Indus Instruments for VisualSonics). Neomycin-resistant gene (neo), Cre recombinase gene driven by testis-specific angiotensin-converting enzyme promoter (tACE-cre), and thymidine kinase gene (TK) are indicated. Arrows and x indicate the position of primers for screening and a mutation site, respectively. B: Southern blot of genomic DNA. After restriction enzyme digestion of genomic DNA with SphI, 5= and 3= probes identify 13.5-kb and 11-kb fragments in the targeted allele, respectively. Both probes hybridize with 20.5-kb fragments in the wildtype (WT) allele. C: DNA sequence analysis of RyR2-L3591D. cDNA encoding the CaM binding site of RyR2 was amplified from total RNA from homozygous (hybrid genetic background) mouse cardiac muscle and sequenced. The RyR2-L3591D mutation was confirmed. A HinfI site created by the L3591D mutation (GACTC) was used for screening the mutant allele.
Transverse aortic constriction. Pressure overload in the left ventricle was induced by transverse aortic constriction (TAC) of 3-moold wild-type and Ryr2 D/D mice as described previously (3) . The aorta was ligated between the innominate and left common carotid arteries with a 7-10 silk suture and a tapered 27-gauge needle placed on top of the aorta. The tapered needle was removed, leaving the suture to produce a defined stenosis of the vessel. Control mice were subjected to a sham operation in which a band was twined around the aorta, but not ligated, and subsequently removed. The skin was closed with separate sutures, and buprenorphine was administered for analgesia. Echocardiography was performed after 4 wk of constriction.
Quantitative RT-PCR. Gene expression was measured by quantitative RT-PCR with the ABI Prism 7700 Sequence Detector (Applied Biosystems) (15) . RNA was isolated from the left ventricle of 4-and 6-mo-old mice with the ABI Prism 6700 Automated Nucleic Acid Workstation according to the manufacturer's protocol. Preparation of heart homogenates and crude membrane fractions. Hearts were homogenized in 20 mM imidazole, pH 7.0, 0.3 M sucrose, 0.15 M NaCl, 0.1 mM EGTA, protease inhibitors (Complete; Roche Applied Science), and 1 mM glutathione (oxidized form) with a Tekmar Tissumizer twice for 5 s at 13,500 rpm (35) . Homogenates were centrifuged for 45 min at 100,000 g in a type 75Ti rotor (Beckman). Pellets were suspended in the aforementioned buffer without EGTA and glutathione to obtain a crude membrane fraction. Homogenates and membranes were stored in small aliquots at Ϫ80°C.
Immunoblot analyses. Homogenates (10 g protein/lane) were separated by 3-12% gradient SDS-PAGE and transferred to nitrocellulose membranes. Membranes were blotted with 2% ECL Advance blocking reagent (Amersham Biosciences) in 0.5% Tween 20-Trisbuffered saline (TBS), pH 7.4 at 24°C for 1 h and probed with primary rabbit polyclonal antibody RyR2-F9221 and secondary peroxidase-conjugated anti-rabbit IgG antibody. Immunoblots were developed with enhanced chemiluminescence and quantified with ImageQuantTL Analysis Software. Glyceraldehyde-3-phosphate dehydrogenase was the loading control.
Single-channel recordings. Single-channel measurements of wildtype and mutant channels were performed in planar lipid bilayers (32) . Measurements were made with symmetrical 0.25 M CsCl, 20 mM Cs HEPES, pH 7.4 with the indicated concentrations of Ca 2ϩ . A strong dependence of single-channel activities on the cis Ca 2ϩ concentration indicated that the large cytosolic "foot" region faced the cis chamber of the bilayers. The trans SR luminal side of the bilayer was defined as ground. Exogenous CaM and S100A1 were added to the cis, cytosolic solution. Electrical signals were filtered at 2 kHz, digitized at 10 kHz, and analyzed as described previously (32 
RESULTS
Mice carrying three mutations in the CaM binding domain of RyR2 (W3587A, L3591D, F3603A; RyR2 ADA ) rapidly develop cardiac hypertrophy and die at ϳ2 wk of age (35) . The triple mutation eliminated CaM-dependent inhibition of RyR2 activity at both diastolic and systolic Ca 2ϩ . To determine whether the phenotype was caused by loss of CaM inhibition at diastolic or systolic Ca 2ϩ , another genetically modified mouse carrying a single amino acid mutation in Ryr2 gene (L3591D) was prepared by gene targeting (Fig. 1) We previously showed that the RyR2-L3591D mutation caused loss of CaM-dependent regulation of channel activity at submicromolar (diastolic) but not micromolar (systolic) Ca 2ϩ when expressed in HEK293 cells (36) . To determine whether CaM regulation of the RyR2-L3591D channel was maintained in mice, membranes isolated from hearts of wild-type and Ryr2 D/D mice were fused with a lipid bilayer (Fig. 2) . RyR2 regulation by CaM, determined by changes in channel P o , was recorded in the presence of 0.2 M or 2 M free cis cytosolic Ca 2ϩ in the absence and on the subsequent addition of cis cytosolic CaM. At 0.2 M cytosolic Ca 2ϩ , addition of 50 nM and 1 M cytosolic CaM resulted in significant inhibition of channel P o of wild-type RyR2, with no changes in P o for RyR2-L3591D (Fig. 2A) . In contrast, in the presence of 2 M Ca 2ϩ , P o of both wild type and RyR2-L3591D decreased at 50 nM and 1 M CaM (Fig. 2B) . Thus CaM regulation of RyR2-L3591D was lost at low Ca 2ϩ but maintained at higher Ca 2ϩ levels. S100A1 is a Ca 2ϩ binding protein reported to bind to the conserved CaM binding region of RyR1 (25) and regulate RyR2 activity (10, 21, 24, 29) . Single-channel measurements in Fig. 3A show that at 0.2 M Ca 2ϩ the addition of 0.3 M and 1 M cytosolic S100A1 reduced P o of wild type. At 2 M Ca 2ϩ , addition of 1 M S100A1 was required for significant wild-type inhibition (Fig. 3B) . No inhibition of RyR2-L3591D channels by S100A1 was observed under any of these conditions. The single-channel data suggest that the L3591D muta- tion impairs CaM and S100A1 regulation of RyR2 at 0.2 M Ca 2ϩ . At 2 M Ca 2ϩ , RyR2-L3591D inhibition by CaM was retained whereas that by S100A1 was lost. One possible explanation is that, in contrast to RyR1 (34), S100A1 and CaM do not compete for the same CaM binding site in RyR2. Nitu et al. (22) , using fluorescence resonance energy transfer, recently reported that S100A1 likely interacts allosterically with the CaM binding domain on RyR2 rather than by a direct interaction. ϩ/ϩ mice, as determined by echocardiography (n ϭ 3, not shown). No major changes in cardiac gross morphology were observed for 6-to 7-mo-old homozygous mutant mice (Fig. 4A) . In homozygous mice, heart weight-tobody weight ratio increased by 11% (P Ͻ 0.003) compared with Ryr2 ϩ/D mice and by 9% (P Ͻ 0.02) compared with wild-type mice (Fig. 4B) . Histological examination showed modest but significant changes in right ventricular wall thickness and cross-sectional area in homozygous mutant mice compared with heterozygous mice (Fig. 4, C and D) . However, the three groups of mice showed no significant changes in septal and left ventricular wall thickness and cross-sectional area.
Ryr2
To determine the effect of the RyR2-L3591D mutation on cardiac function, echocardiography was performed on conscious 6-mo-old animals ( Table 1 ). Significant increases in left ventricular end-diastolic and end-systolic dimensions were observed in heterozygous mice compared with wild-type mice. Left ventricular posterior diastolic and systolic wall thicknesses were increased in homozygous mice compared with heterozygous mice. Heart rate, fractional shortening, interventricular septum, and left ventricular diastolic and systolic posterior wall thicknesses were all similar among the three genotypes, suggesting limited alterations in cardiac morphology and contractility of the mutant mice.
Relevant gene expression in 6-mo-old wild-type and Ryr2 D/D mice was determined by quantitative RT-PCR. ANP mRNA increased 1.8-fold in the hearts of homozygous mice compared with wild type (Fig. 5) . This suggests that the RyR2-L3591D mutation elicited a modest hypertrophic response in Ryr2 D/D mice (16) . However, mRNA levels of other genes associated with cardiac remodeling and Ca 2ϩ handling were not altered compared with wild-type (Fig. 5) . These included cardiac hypertrophy-associated genes ␤-MHC and BNP and genes for Ca 2ϩ handling proteins Ca v 1.2, RyR2, IP 3 R, CSQ2, SERCA2a, and NCX1.
Cardiac muscle SR Ca 2ϩ handling. The SR Ca 2ϩ handling properties of wild-type and Ryr2 D/D mice were compared in heart homogenates of 6-mo-old mice. In Fig. 6A, a (Table 2) . Likewise, immunoblot analysis did not reveal significant differences in RyR2 expression among the three genotypes (Fig. 6B) .
45 Ca 2ϩ uptake rates, a measure of SERCA activity by cardiac muscle isolates, were not altered ( Table 2) .
Pressure overload induces a modest hypertrophic response in Ryr2
D/D mice. To determine whether Ryr2 D/D mice are capable of a cardiac hypertrophic response under conditions of pressure overload, 3-mo-old Ryr2 D/D and wild-type mice were subjected to TAC for 4 wk. TAC induced a significant 1.4-fold increase in heart weight-to-body weight ratio in Ryr2 D/D mice compared with 1.1-fold increase in wild-type mice (Table 3) . Echocardiography indicated that TAC increased interventricular septum dimensions and left ventricular posterior wall diastolic thickness in homozygous mice compared with shamoperated wild-type mice, without significantly affecting overall cardiac performance.
To further investigate the response of Ryr2 D/D mice to pressure overload, mRNA levels of cardiac hypertrophy-related genes were measured by quantitative RT-PCR. No significant changes in ␣-MHC, ␤-MHC, and BNP mRNA levels were observed (Fig. 7) . However, there was a significant twoto threefold increase in ANP levels of sham-operated Ryr2 D/D animals compared with sham-operated wild-type mice. In pressure-overloaded mice, 1.3-and 2.1-fold increases in ANP mRNA levels were observed in wild-type and homozygous mutant mice, (13) 3.76 Ϯ 0.34 (6) Values are means Ϯ SE for number of heart preparations indicated in parentheses. Bmax, maximum binding capacity. respectively, compared with sham-operated animals. Together, the data suggest that small differences between mutant and wildtype mice under baseline conditions become more prominent during pressure overload of Ryr2 D/D mice.
DISCUSSION
Accumulating evidence suggests that a dysfunctional RyR2 calcium channel has a major role in the genesis of cardiomyopathy. Aberrant phosphorylation, oxidation, and S-nitrosylation of RyR2, which cause leaky Ca 2ϩ channels with an increased activity at diastolic Ca 2ϩ , have been implicated in arrhythmias and heart failure (1, 6, 18, 30, 37 ADA/ADA mice. Some differences were noted between the two mutant genotypes as well. Heterozygous mice had a lower heart weight-tobody weight ratio but increased right ventricular wall thickness and cross-sectional area and reduced posterior wall thickness as determined by echocardiography compared with homozygous mice. RyR2 is composed of four identical subunits, and, assuming a random distribution, 15 of 16 RyR2 have at least one wild-type subunit in heterozygous mice. Since the binding of about one CaM is sufficient to inhibit the tetrameric RyR (2), a majority of RyR2s in heterozygous mice were likely inhibited by CaM at systolic Ca 2ϩ . Additional studies are required to learn how the changes in CaM occupancy of heterozygous and homozygous mutant RyR2s affect cardiac morphology.
Stimulation of neonatal cardiomyocytes with endothelin-1 (9) and pacing-induced heart failure in canines (12) resulted in partial dissociation of CaM from RyR2. Expression of CaM isoform with higher binding affinity restored normal SR Ca 2ϩ handling in cardiomyocytes from failing hearts (12) . In the present study, TAC was used to learn how Ryr2 D/D mice respond to conditions of stress. We found that pressure overload increased heart weightto-body weight ratio in Ryr2 D/D mice, with only small changes in cardiac parameters of wild-type and homozygous mice subjected to TAC compared with sham-operated mice. RT-PCR indicated a modest increase in ANP mRNA levels in mice subjected to TAC. The results suggest that inhibition of RyR2 by CaM and S100A1 at diastolic Ca 2ϩ may preserve heart weight-to-body weight ratio and ANP expression during stress such as exercise. However, it should be noted that even under pressure overload of Ryr2 D/D mice, changes in heart growth and function were smaller than those in 10-day old Ryr2 ADA/ADA mice not subjected to TAC. S100A1 is an EF hand Ca 2ϩ binding protein expressed at high levels in the heart (13) . Evidence indicates that S100A1 regulates intracellular Ca 2ϩ homeostasis and cardiac contraction. S100A1, like CaM, regulates cardiac Ca 2ϩ handling proteins such as RyR2, voltage-dependent L-type Ca 2ϩ channel, and the SERCA2a-PLN complex (10, 21, 24, 29) . [ 3 H]ryanodine binding and Ca 2ϩ spark measurements indicated that S100A1 has multiple effects on RyR2 channel activity. In [ 3 H]ryanodine binding studies, low concentrations of S100A1 increased RyR2 activity at diastolic 0.1 M Ca 2ϩ but high concentrations decreased activity. At systolic Ca 2ϩ , S100A1 activated RyR2 (14, 20) . In permeabilized cardiomyocytes, Ca 2ϩ spark frequency decreased in response to exogenously added S100A1 (28) . Similar to previous reports, we observed S100A1 effects on RyR2 function. However, this is the first study that describes a genetically modified mouse with a loss of S100A1 binding to RyR2, thus avoiding the multiple effects of gene delivery such as altering the regulation of SERCA and L-type Ca 2ϩ channel. Single-channel recordings showed that 1 M S100A1 inhibited wild-type RyR2 at 0.2 and 2 M Ca 2ϩ . The RyR2-L3591D mutation eliminated the inhibitory effect of S100A1 on RyR2 at both Ca 2ϩ concentrations. Nevertheless, Ryr2 D/D mice did not demonstrate major changes in cardiac function and growth. Together, the results suggest that S100A1 has a limited role in regulating RyR2 in vivo under normal conditions.
In and by S100A1 at diastolic and systolic Ca 2ϩ in mice had only modest effects on cardiac morphology and function. 
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